The multinational pharmaceutical company showcased their new product launches in Paris at one of the most influential medical-aesthetic congresses in the world.
Doctors Adrián Gaspar and Sabine Zenker shared the most recent results of their studies applying mesoestetic laboratory solutions and products.

mesoestetic were delighted to be present at the 2019 IMCAS World Congress, one of the most important and influential aesthetic-medicine events in the world. This year the event hosted over 10,000 participants during its 21st edition and where mesoestetic Pharma Group, announced its latest developments. The pharmaceutical company presented its new solutions in hyperpigmentation with tranexamic acid, a new treatment to reduce aesthetic concerns of the periocular area combining a specific peel and mesotherapy. They also launched their new innovation at home product – ha densimatrix; A serum concentrate based on hyaluronic acid with different molecular forms that provides the skin with a moisturising, antiaging, and filling action that looks to attract great interest in 2019. In this major medical comference, mesoestetic Pharma Group had presence in the congress speeches with two renowned international physicians presenting the most recent advances and studies performed with the company solutions.

• Dr. Adrián Gaspar, (Argentina)

A gynaecologist expert in gynaeco-aesthetics and chairman of the Latin American Society of Aesthetic and Functional Gynaecology, shared his experience and the results of his studies on the use of carboxytherapy, mesotherapy and fillers in the treatment of the aging and functional regeneration processes of the genital area. Dr. Gaspar also talked about studies performed with the mesofiller and mesohyal products and the use of the technology within the mct injector by mesoestetic, combining carboxytherapy and mesotherapy techniques in one convenient to use device.

• Dr. Sabine Zenker, (Germany)

An expert in micro invasive and non-invasive rejuvenating treatments, participated in the presentation “Review of current evidence of antioxidants and skin aging”, talking about the role of antioxidant active ingredients through different solutions and treatments. The aox ferulic concentrate, the c.prof 210 transcutaneous solution and the depigmenting melanoplus mesopeel by mesoestetic Pharma Group were some of the examples used during this lecture.

IMCAS World Congress has again been the ideal platform for industry companies to present their new products and meet thousands of dermatologists, plastic surgeons and aesthetic medicine professionals. The congress has provided three days full of high-quality learning with over 310 hours of teaching and over 700 expert speakers.